7th Annual Translational Science Symposium – In Memory of David Seldin, MD, PhD

The BU-CTSI and the BMC Grayken Center for Addiction are pleased to announce their co-sponsorship of a symposium entitled “Addiction Medicine 2018: Translational Science at the Cutting Edge” featuring ground breaking addiction medicine research and policy initiatives. Featured confirmed speakers will include Nora Volkow, MD, Director of the National Institute of Drug Abuse (NIDA), Sandro Galea, MD, MPH, DrPH, Dean, Boston University School of Public Health, and Monica Bharel, MD, MPH, Commissioner, Massachusetts Department of Public Health. Additional speakers will outline innovative initiatives being explored at BU/BMC in addiction treatment, and a scientific abstract forum will be held to feature the diversity of addiction-themed research initiatives throughout the institutions.

May 3, 2018
Hiebert Lounge, Instructional Building, Boston University School of Medicine
72 East Concord Street, 14th Floor, Boston, MA 02118

Symposium Agenda
Watch AddictionSymposium2018 Playlist

Symposium Photos

Guest Speakers

Nora D. Volkow, MD – Keynote Speaker
Director, National Institute on Drug Abuse (NIDA)
Addressing the Opioid Crisis: A Key Role for Translational Science
View PowerPoint Slides
Senator Ed Markey – Closing Remarks
U.S Senator of Massachusetts
Michael G. Kurilla, MD, PhD – NCATS – Perspective
Director, Division of Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
NCATS – Perspective
Kate Walsh, MPH
President & CEO, Boston Medical Center
Karen Antman, MD
Provost, Boston University Medical Campus
Dean, Boston University School of Medicine
Michael Botticelli
Executive Director, Grayken Center for Addiction
David M. Center, MD
Director, BU CTSI
Sandro Galea, MD, MPH, DrPH
Dean and Robert A. Knox Professor Boston University School of Public Health
The Opioid Epidemic in Context: On Mitigating the Epidemic, and Preventing the Next One
View PowerPoint Slides
Monica Bharel, MD, MPH
Commissioner of the Massachusetts Department of Public Health; Clinical Assistant Professor BUSM
Addressing the Opioid Epidemic Through a Public Health Lens
View PowerPoint Slides
Jorge Delva, PhD, MSW
Dean of Boston University School of Social Work
The Opioid Epidemic in an Uncertain World: Are People Being Pushed Over the Edge?
View PowerPoint Slides
Sarah M. Bagley, MD
Assistant Professor of Medicine BUSM;
Clinical Addiction Research & Education (CARE) Unit Faculty
Engaging Emerging Adults in Care After Nonfatal Opioid Overdose
View PowerPoint Slides
Jessie M. Gaeta , MD
Assistant Professor of Medicine BUSM; Chief Medical Officer,
Boston Health Care for the Homeless Program
Harm Reduction and Research: Evaluation of SPOT
View PowerPoint Slides
John Renner, MD
Professor of Psychiatry; Director Addiction Psychiatry Fellowship; Associate Chief of Psychiatry VA Boston Healthcare System
VA’s Response to the Opioid Epidemic. Translational Science in Action
View PowerPoint Slides
Colleen T. LaBelle, MSN, RN-BC, CARN
Program Director STATE OBAT; Executive Director MA IntNSA;
Clinical Addiction Research & Education (CARE) Unit Faculty
New Approaches to Disseminating Treatment: Technology, Low Barrier MAT and Prison Health
View PowerPoint Slides
Marc R. LaRochelle, MD, MPH
Assistant Professor of Medicine BUSM;
Clinical Addiction Research & Education (CARE) Unit Faculty
Touchpoints Prior to Opioid Overdose Death
View PowerPoint Slides
Tae Woo Park, MD, MSc
Addiction Psychiatrist, BMC; Assistant Professor of Psychiatry BUSM
Benzodiazepine Use in Opioid Agonist Treatment: The Risks and the Benefits
View PowerPoint Slides
Richard Saitz, MD, MPH, FACP, DFASAM
Professor BUSM and BUSPH, Chair, Department of Community Health Sciences BUSPH
Research on Integrating Addiction and Medical Care at BMC: The First 25 Years
View PowerPoint Slides
Jeffrey H. Samet, MD, MA, MPH
Professor of Medicine, Chief, Section of General Internal Medicine BMC,
Vice Chair for Public Health, Department of Medicine
Workforce Development: BUSM/BMC Addiction Education and Policy Initiatives
View PowerPoint Slides
Stacey Sigmon, PhD
Research Associate Professor of Psychology & Psychiatry,
University of Vermont; Director, The Chittenden Clinic
Interim Buprenorphine Dosing for Reducing Illicit Drug Use and Associated Risks Among Waitlisted Opioid-Dependent Adults
View PowerPoint Slides

Other Distinguished Guests

Joan Davis Nagel, MD, MPH
Medical Officer, Division of Clinical Innovation,
National Center for Advancing Translational Sciences (NCATS)
Government Representatives – TBA

 

 

 

 

 



Grayken Center logo (002)